Diagnostics
Diagnostics firm Ikonisys lands $3.8M
August 5, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | News | CommentsIkonisys Inc., a New Haven, Conn.-based diagnostics device firm, has raised $3.8 million of a planned $12 million equity and warrants offering, according to a regulatory filing. The company develops a platform that serves as the basis of diagnostic products for identifying cancer and birth defects.
Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
August 5, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsIRVINE, California , and AMSTERDAM , August 5, 2010 /- Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington...
OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research
August 4, 2010 11:34 am | by Bio-Medicine.Org | News | CommentsIRVINE, Calif. , Aug. 4 /- OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, is pleased to announce their partnership with The Gynecologic Oncology Group (GOG) through the...
Technology transfer: 25 years at Baylor College of Medicine
August 4, 2010 9:33 am | by Baylor College of Medicine | News | CommentsThe Baylor Licensing Group – the office responsible for transferring research results and discoveries developed by Baylor College of Medicine faculty to the marketplace – is celebrating 25 years at the College. More than 200 diagnostic, clinical and research products have...
Detecting Concussion on the Football Field
August 3, 2010 8:34 pm | by Massachusetts Institute of Technology | News | CommentsNew device shows that brain injury may linger even after obvious symptoms disappear.
Invivo Wins Medical Design Excellence Award for Prostate Solutions
August 3, 2010 4:36 pm | by Bio-Medicine.Org | News | CommentsPEWAUKEE, Wis. , Aug. 3 /- On June 9, 2010 , Invivo was recognized with a 2010 Gold Medical Design Excellence Award (MDEA) for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City 's...
AACR Hosts Molecular Diagnostics Conference in Denver, Colo.
August 3, 2010 7:34 am | by AACR | News | CommentsThis year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and...
Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010
August 3, 2010 4:33 am | by Bio-Medicine.Org | News | CommentsBEIJING , Aug. 3 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM ), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results for the...
News briefs from the August issue of Chest
August 2, 2010 9:33 pm | by EurekAlert | News | Comments(American College of Chest Physicians) News briefs from the August issue of Chest discuss how diabetes may reduce lung function; how aerobic activity helps improve asthma symptoms; and how home sleep testing may be a viable option.
Georgia Tech Awarded a $20M Center for Chemical Innovation
August 2, 2010 6:33 am | by Georgia Tech Institute of Technology | News | CommentsA team of institutions led by Georgia Tech has been awarded $20 million from the National Science Foundation and National Aeronautics and Space Administration to pursue research that could lead to a better understanding of how life started on Earth.
Hepatitis C Therapeutics Market - Taiwan
August 2, 2010 1:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK , Aug. 2 /-Reportlinker.com announces that a new market research report is available in its catalogue: Hepatitis C Therapeutics Market - Taiwan http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---T... This rese...
Socioeconomic status predicts survival of Canadian cancer patients
August 1, 2010 9:33 pm | by EurekAlert | News | Comments(American Cancer Society) A new analysis finds that cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups.
Short and long sleep durations are independent risk factors for cardiovascular disease
July 31, 2010 9:31 pm | by EurekAlert | News | Comments(American Academy of Sleep Medicine) The risk of any cardiovascular disease for adults who reported sleeping five hours per day or less was more than two times higher than that of people who reported a daily sleep duration of seven hours (adjusted odds ratio = 2.20). Participants who...
Transforaminal steroid injection for lumbar radicular pain proves superior to placebo
July 29, 2010 10:33 pm | by EurekAlert | News | Comments(Wiley-Blackwell) A recent study from Australian researchers determined that transforaminal injection of steroids was a viable alternative to surgery for lumbar radicular pain due to disc herniation. Full details of the study appear in the August issue of Pain Medicine, a journal...
Gen-Probe 2Q net income rises 42 percent on sales
July 29, 2010 4:45 pm | by The Associated Press | News | CommentsDiagnostic test maker Gen-Probe Inc. said Thursday its second-quarter net income jumped 42 percent on higher revenue from blood screening and women's health products.The company earned $28.1 million, or 57 cents per share, up from $19.8 million, or 38 cents per share, during the same period a...
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
July 29, 2010 4:33 am | by Becton, Dickinson and Company | News | Comments(July 28, 2010) -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the promotion of Vincent A. Forlenza, President, who assumes the title of Chief Operating Officer in addition to his current title. Mr. Forlenza
Glucose Monitors Get Under the Skin
July 28, 2010 8:34 pm | by Massachusetts Institute of Technology | News | CommentsImplantable devices work in diabetic pigs for over a year--human tests could be next.
Siemens Showcases Broad Array of Innovative Diagnostic Solutions at 2010 AACC and ASCLS Annual Meetings and Clinical Lab Expo
July 28, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsANAHEIM, Calif. , July 28 /- Siemens Healthcare Diagnostics is showcasing a broad array of new products, services and solutions for clinicians at the American Association for Clinical Chemistry's 2010 Clinical Lab Expo in Anaheim, California from July 27 through July 29, 2010 (Booth...
Nanoblasts Move Molecules, Proteins and DNA into Living Cells
July 28, 2010 7:32 am | by Georgia Tech Institute of Technology | News | CommentsUsing chemical "nanoblasts" that punch tiny holes in the protective membranes of cells, researchers have demonstrated a new technique for getting therapeutic small molecules, proteins and DNA directly into living cells.
Speeding Up Diagnosis of Infectious Disease
July 27, 2010 8:35 pm | by Massachusetts Institute of Technology | News | CommentsA startup is developing sequencing-based tests that could detect infections within 24 hours.
Reform of primary care could reduce diagnostic errors
July 27, 2010 12:33 pm | by Baylor College of Medicine | News | CommentsErrors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant,...
Axela acquires Xceed Molecular
July 27, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | News | CommentsXceed Molecular, based in Toronto and Wellesley, has been acquired by Anaheim, Calif., based Axela Inc. which plans to provide clinical researchers with a suite of products for enhanced analysis of proteins, pathogens, DNA and RNA.
BD Board of Directors Elects Christopher Jones
July 27, 2010 8:34 am | by Becton, Dickinson and Company | News | Comments(July 26, 2010) -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it has elected Christopher Jones to its Board of Directors, effective today. Mr. Jones, 55, is the former Chief Executive Of
Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
July 27, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsSHENZHEN, China , July 27 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced it will attend the 2010 American Association for Clinical Chemistry (AACC) conference in...
Moffitt Cancer Center and CvergenX, Inc. Sign Licensing Agreement
July 27, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsTAMPA, Fla. , July 27 /- Moffitt Cancer Center and CvergenX, Inc. , announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™....
